The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease. - Wikidata - awgldk - TriplyDB

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.

http://www.wikidata.org/entity/Q44801837

about

A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's disease Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology Body fluid biomarkers in Alzheimer's disease Novel plasma biomarker surrogating cerebral amyloid deposition.Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's disease Optimizing Human Bile Preparation for Two-Dimensional Gel Electrophoresis.The incubation period of Alzheimer's disease and the timing of tau versus amyloid misfolding and spreading within the brain.Plasma tau in Alzheimer disease.Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease.Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress.Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease.Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging.Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome.Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects.Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study.

P2860

Q26771808-4B3700EC-F57E-4B20-99F1-6E0AB47BC9BB Q26774743-B8A86FD9-FBEE-4B50-BB19-D9BF8BA2FA45 Q26830098-DC63A823-8812-4B62-BDBC-6BC5D0816EDD Q35074431-4BC35175-EA94-4F96-BA0A-2F6B626EC860 Q35843380-70D0BE9E-45E2-4A57-B3E5-22A17C30236A Q36591042-AD066710-32AD-4BD9-A94D-7B27DEC9BAC3 Q36762790-F4D5402C-D460-45E4-8A6C-C56D7D48B33D Q37384690-DE3E8E95-ACFB-48CA-B3D9-2835F1023D9D Q37654102-8DC7CDD3-A421-45D3-BCA4-8CE9E222D674 Q38980003-713B7AA9-B498-4AA2-8F69-9FBF69783C94 Q39451605-74D80323-FAA9-45A8-BC1B-F90BDC418DBE Q40129154-422405EC-6B9C-4670-A4D6-E55B44F8EEAF Q41600844-3CF32C31-A697-48C2-93EF-B34C08064309 Q45956072-B359F2ED-1DDC-47E1-A659-A2B125B5C4F2 Q52148328-256F729A-751C-4FAB-8A4A-3F62CDB8A813 Q52594155-0A62A9AF-8504-46D5-AEDF-E3228F39EFBB

P2860

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.

http://www.wikidata.org/entity/Q44801837

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.

@en

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.

@nl

type

label

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.

@en

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.

@nl

prefLabel

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.

@en

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.

@nl

P1433

Q44801837-FA45ACA6-A8B9-4E82-9839-FD52250B798D

P1476

Q44801837-B91475B3-9A9E-47DE-A8BC-C32C10EB603D

P2093

Q44801837-0E95B7FE-4B64-4759-B7BB-E689C8F5E12D

Q44801837-308B4A81-BA70-40F7-9378-EB5D0083FC02

Q44801837-3E12AC1F-A6C9-47AF-B2A2-40750F92A617

Q44801837-AC25AC62-9DBD-44DC-A1E5-6C7A245315B9

Q44801837-D821891A-7BEE-4BAE-A0EF-A246CCFFE465

Q44801837-DB1717C1-4F93-4F2A-AA0C-4925F90B352B

Q44801837-E015C821-4CE0-4333-AE22-C54B625BBDBA

Q44801837-F77DDE9F-A955-46C6-8A09-C85F5A1F1A0D

Q44801837-FC658A2A-DDD9-41CD-AD56-3F8DC90616F8

P2860

Q44801837-11F25717-CECD-428D-A33B-85C378DE4636

Q44801837-1A4428C9-7F58-4A80-B64E-809A1744B563

Q44801837-1E2B020B-657F-4074-A449-370FA4A0B562

Q44801837-23482052-9867-4006-B53B-0C0FF7C90F9D

Q44801837-23B7AB2D-E71C-48E3-8064-0B1BD76EC1C4

Q44801837-26C6FE4B-6AD7-4C1F-AEC0-AD716CCAE053

Q44801837-37184997-6CF5-437D-9C01-827552554C2C

Q44801837-3B2B8BC3-9972-4711-BC9D-AA0E294181F2

Q44801837-3C528B60-DB57-469C-9D2F-49C1B7F79A80

Q44801837-43D608C1-3ED9-41B8-9816-16CB94D28EE4

P304

Q44801837-95F6478F-C8F1-4243-97A3-06E8A7571A2F

P31

Q44801837-44302A3D-50FC-4B6C-9040-C95D8387D6BB

P356

Q44801837-11840728-8D09-4563-8796-EC4235E0ACCF

P407

Q44801837-085B6E89-57D5-418C-B054-0F30DD382926

P433

Q44801837-BABC545F-139B-4CA4-ADBD-6477C6B2F0EA

P478

Q44801837-83D67843-CD13-4ADA-9126-411339CBA56B

P577

Q44801837-3931DF48-92D3-4DC6-9F81-FF30ACF9B8C5

P5875

Q44801837-3A99CA3E-07EC-4877-B2B9-98DF3ACB7C7C

P698

Q44801837-E7118880-590D-4850-ADF8-22CCCBC51F25

P921

Q44801837-AF24E513-28D4-431E-8D9A-B10C1B0627BD

Q44801837-F1BF5CCF-962F-470D-B2C8-142C286D1150

P356

P1433

International Journal of Geriatric Psychiatry

P1476

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.

@en

P2093

Guanjun Li

http://www.w3.org/2001/XMLSchema#string

Mingyuan Zhang

http://www.w3.org/2001/XMLSchema#string

Ning Su

http://www.w3.org/2001/XMLSchema#string

Shifu Xiao

http://www.w3.org/2001/XMLSchema#string

Tao Wang

http://www.w3.org/2001/XMLSchema#string

Xia Li

http://www.w3.org/2001/XMLSchema#string

Yiru Fang

http://www.w3.org/2001/XMLSchema#string

Yuanyuan Liu

http://www.w3.org/2001/XMLSchema#string

Zhiguang Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Global prevalence of dementia: a Delphi consensus study

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study

Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

Current concepts in mild cognitive impairment.

Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.

Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Alzheimer's disease and mild cognitive impairment

Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease.

P304

713-719

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GPS.4053

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259249150

http://www.w3.org/2001/XMLSchema#string

P698

24318929

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease